709 related articles for article (PubMed ID: 30177752)
1. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.
Bonora M; Wieckowski MR; Sinclair DA; Kroemer G; Pinton P; Galluzzi L
Nat Rev Cardiol; 2019 Jan; 16(1):33-55. PubMed ID: 30177752
[TBL] [Abstract][Full Text] [Related]
2. Targeting mitochondria for cardiac protection.
Hernández-Reséndiz S; Buelna-Chontal M; Correa F; Zazueta C
Curr Drug Targets; 2013 May; 14(5):586-600. PubMed ID: 23458575
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders.
Kim HK; Han J
Adv Exp Med Biol; 2017; 982():621-646. PubMed ID: 28551810
[TBL] [Abstract][Full Text] [Related]
4. Thymidine phosphorylase: A potential new target for treating cardiovascular disease.
Li W; Yue H
Trends Cardiovasc Med; 2018 Apr; 28(3):157-171. PubMed ID: 29108898
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Dysfunction in Cardiovascular Aging.
Hoppel CL; Lesnefsky EJ; Chen Q; Tandler B
Adv Exp Med Biol; 2017; 982():451-464. PubMed ID: 28551802
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Dysfunction and Myocardial Ischemia-Reperfusion: Implications for Novel Therapies.
Lesnefsky EJ; Chen Q; Tandler B; Hoppel CL
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():535-565. PubMed ID: 27860548
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.
Walters AM; Porter GA; Brookes PS
Circ Res; 2012 Oct; 111(9):1222-36. PubMed ID: 23065345
[TBL] [Abstract][Full Text] [Related]
8. Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management.
Yehualashet AS; Belachew TF; Kifle ZD; Abebe AM
Vasc Health Risk Manag; 2020; 16():353-365. PubMed ID: 32982263
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases.
Kornfeld OS; Hwang S; Disatnik MH; Chen CH; Qvit N; Mochly-Rosen D
Circ Res; 2015 May; 116(11):1783-99. PubMed ID: 25999419
[TBL] [Abstract][Full Text] [Related]
10. The Future of Cardiovascular Therapeutics.
MacRae CA; Roden DM; Loscalzo J
Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
[No Abstract] [Full Text] [Related]
11. Cardiovascular Mitochondrial Dysfunction Induced by Cocaine: Biomarkers and Possible Beneficial Effects of Modulators of Oxidative Stress.
Graziani M; Sarti P; Arese M; Magnifico MC; Badiani A; Saso L
Oxid Med Cell Longev; 2017; 2017():3034245. PubMed ID: 28593024
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria as a therapeutic target in heart failure.
Bayeva M; Gheorghiade M; Ardehali H
J Am Coll Cardiol; 2013 Feb; 61(6):599-610. PubMed ID: 23219298
[TBL] [Abstract][Full Text] [Related]
13. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics.
Marzetti E; Csiszar A; Dutta D; Balagopal G; Calvani R; Leeuwenburgh C
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H459-76. PubMed ID: 23748424
[TBL] [Abstract][Full Text] [Related]
14. Mitofilin in cardiovascular diseases: Insights into the pathogenesis and potential pharmacological interventions.
Chaurembo AI; Xing N; Chanda F; Li Y; Zhang HJ; Fu LD; Huang JY; Xu YJ; Deng WH; Cui HD; Tong XY; Shu C; Lin HB; Lin KX
Pharmacol Res; 2024 May; 203():107164. PubMed ID: 38569981
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease.
Ong SB; Kalkhoran SB; Cabrera-Fuentes HA; Hausenloy DJ
Eur J Pharmacol; 2015 Sep; 763(Pt A):104-14. PubMed ID: 25987420
[TBL] [Abstract][Full Text] [Related]
16. Targeting cell death.
Hausenloy DJ; Scorrano L
Clin Pharmacol Ther; 2007 Oct; 82(4):370-3. PubMed ID: 17851576
[TBL] [Abstract][Full Text] [Related]
17. SIRT6 in Regulation of Mitochondrial Damage and Associated Cardiac Dysfunctions: A Possible Therapeutic Target for CVDs.
Divya KP; Kanwar N; Anuranjana PV; Kumar G; Beegum F; George KT; Kumar N; Nandakumar K; Kanwal A
Cardiovasc Toxicol; 2024 Jun; 24(6):598-621. PubMed ID: 38689163
[TBL] [Abstract][Full Text] [Related]
18. ER membranes associated with mitochondria: Possible therapeutic targets in heart-associated diseases.
Silva-Palacios A; Zazueta C; Pedraza-Chaverri J
Pharmacol Res; 2020 Jun; 156():104758. PubMed ID: 32200027
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction in cardiovascular disease.
Ballinger SW
Free Radic Biol Med; 2005 May; 38(10):1278-95. PubMed ID: 15855047
[TBL] [Abstract][Full Text] [Related]
20. Editorial (Thematic Issue: Mitochondrial and Metabolism: Novel Targets for Heart Failure).
Xu L; Sun A
Curr Pharm Des; 2016; 22(31):4743. PubMed ID: 27790961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
